OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated ...

IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...

Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset, expanded ...

A latest research, published in Nature Communications, revealed that our immune systems and oral health may benefit from ...

The giant DNA loops were discovered through a careful study of saliva samples from 56 volunteers, with further tests ...

Detailed price information for Charles River Laboratories Intl (CRL-N) from The Globe and Mail including charting and trades.

Viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is projected to hit the market valuation of US$ 20.30 billion by 2033 at a CAGR of 19.1% during the forecast ...

University of Iowa researchers developed a gene therapy that could prevent craniosynostosis, a condition where babies’ skull ...

The plasmid DNA manufacturing market offers significant opportunities due to the outsourcing trend and rising demand in ...

The Global DNA Manufacturing Market is estimated to be valued at USD 6.44 Bn in 2025 and is expected to reach USD 19.56 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.2% from 2025 ...

RIVERHEAD, N.Y. (AP) — A New York judge on Wednesday allowed DNA evidence obtained through advanced techniques into the forthcoming murder trial of the man accused of being Long Island’s Gilgo Beach ...

The webcast will be available for 90 days at the link above or under the News & Investors tab of the Imunon website at IMUNON is a clinical-stage biotechnology company focused on advancing a ...